The 3 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +500.18% increase from the last price of 1.00.
The current consensus among 3 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Aug 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.